Neurocrine Biosciences to Present at the 2026 Jefferies Global Healthcare Conference
Executives will present the company’s portfolio and pipeline, with the webcast available on Neurocrine’s investor site and archived for about one month.
8 Articles
8 Articles
Lycia Therapeutics to Present at the 2026 Jefferies Global Healthcare Conference
SOUTH SAN FRANCISCO, Calif., Nov. 11, 2026 (GLOBE NEWSWIRE) -- Lycia Therapeutics, Inc. (Nasdaq: LYCA), a clinical-stage biotechnology company focused on the discovery and development of novel therapeutics designed to degrade disease-causing extracellular proteins, with an initial focus on addressing…
Neurocrine Biosciences to Present at the 2026 Jefferies Global Healthcare Conference
SAN DIEGO, Nov. 10, 2026 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that its executives will participate at the 2026 Jefferies Global Healthcare Conference in London at 3:30 p.m. Greenwich Mean Time (10:30 a.m. Eastern Time) on November…
AC Immune to Present at Jefferies Global Healthcare Conference 2026
Lausanne, Switzerland, November 11, 2026 — AC Immune SA (NASDAQ: ACIU), a clinical-stage biopharma company targeting the key pathologic misfolded proteins and pathways that drive neurodegenerative diseases, today announced that Martin Zügel, Interim CEO, will present and participate in a fireside chat at the annual Jefferies Global Healthcare Conference 2026, taking place November 16-19 in […]
Coverage Details
Bias Distribution
- 83% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
